Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Susanne Haufe, MS, Annika Erbacher, MD, Ingo Müller, MD, PhD, Rupert Handgretinger, MD, PhD, Michael Hofbeck, MD, PhD, Gunter Kerst, MD, PhD

Blood (2011) 118 (21): 2161.

https://doi.org/10.1182/blood.V118.21.2161.2161

Published: 2011

Journal Articles

Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Michaela Döring, MD, Olivia Blume, MS, Susanne Haufe, MS, Ulrike Hartmann, Pharmacologist, Astrid Kimmig, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD, PhD

Blood (2011) 118 (21): 3011.

https://doi.org/10.1182/blood.V118.21.3011.3011

Published: 2011

Journal Articles

Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation.

Michaela Döring, MD, Ingo Müller, MD, Annika Erbacher, Rupert Handgretinger, MD, PhD, Michael Hofbeck, MD, PhD, Gunter Kerst, MD

Blood (2010) 116 (21): 1499.

https://doi.org/10.1182/blood.V116.21.1499.1499

Published: 2010

Journal Articles

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Judith Böhringer, Birgit Kustermann-Kuhn, PhD, Friederike Gieseke, PhD, Annika Erbacher, PhD, Michaela Döring, MD, Christiane Kehrer, MD, Peter Lang, MD, Ingeborg Krägeloh-Mann, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD

Blood (2010) 116 (21): 3727.

https://doi.org/10.1182/blood.V116.21.3727.3727

Published: 2010

Journal Articles

Safety and Feasibility of Posaconazole as Oral Antifungal Prophylaxis In Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation.

Michaela Döring, MD, Carsten Müller, MD, Astrid Kimmig, MD, Carl-Philipp Schwarze, MD, Peter Lang, MD, Rupert Handgretinger, MD, Ingo Müller, MD

Blood (2010) 116 (21): 1308.

https://doi.org/10.1182/blood.V116.21.1308.1308

Published: 2010

NARROW

Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation

Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation.

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Safety and Feasibility of Posaconazole as Oral Antifungal Prophylaxis In Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation

Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation.

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Safety and Feasibility of Posaconazole as Oral Antifungal Prophylaxis In Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only